These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2190895)

  • 1. [Serum amyloid A (SAA) in rheumatic diseases and in systemic amyloidosis].
    Henkin Y; Zimlichman S; Sukenik S
    Harefuah; 1990 Apr; 118(7):422-5. PubMed ID: 2190895
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
    Maury CP; Wegelius O
    Int J Tissue React; 1985; 7(5):405-7. PubMed ID: 4055265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview.
    Obici L; Raimondi S; Lavatelli F; Bellotti V; Merlini G
    Arthritis Rheum; 2009 Oct; 61(10):1435-40. PubMed ID: 19790131
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
    Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
    Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid A protein--current status.
    Maury CP
    Scand J Rheumatol; 1984; 13(2):97-100. PubMed ID: 6610935
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA).
    Marhaug G; Sletten K; Husby G
    Clin Exp Immunol; 1982 Nov; 50(2):382-9. PubMed ID: 7151331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A protein concentration measured by radial immunodiffusion in Abyssinian and non-Abyssinian cats.
    DiBartola SP; Reiter JA; Cornacoff JB; Kociba GJ; Benson MD
    Am J Vet Res; 1989 Aug; 50(8):1414-7. PubMed ID: 2506782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein SAP (serum amyloid P-component) in Waldenström's macroglobulinaemia, multiple myeloma and rheumatic diseases.
    Strachan AF; Johnson PM
    J Clin Lab Immunol; 1982 Sep; 8(3):153-6. PubMed ID: 6813503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.
    van der Hilst JC; Drenth JP; Bodar EJ; Bijzet J; van der Meer JW; Simon A;
    Amyloid; 2005 Jun; 12(2):115-9. PubMed ID: 16011988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum amyloid A (SAA) 1, SAA 2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis].
    Okuda Y; Yamada T; Takasugi K; Takeda M; Nanba S; Onishi M; Miyamoto T; Inoue Y
    Ryumachi; 1999 Feb; 39(1):3-10. PubMed ID: 10332210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental amyloidosis in the hamster: correlation between hamster female protein levels and amyloid deposition.
    Snel FW; Niewold TA; Baltz ML; Hol PR; Van Ederen AM; Pepys MB; Gruys E
    Clin Exp Immunol; 1989 May; 76(2):296-300. PubMed ID: 2474395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
    de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
    Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate inhibits reactive amyloidosis in mice.
    Murai T; Yamada T; Miida T; Arai K; Endo N; Hanyu T
    Arthritis Rheum; 2002 Jun; 46(6):1683-8. PubMed ID: 12115201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases.
    Benson MD; Cohen AS
    Arthritis Rheum; 1979 Jan; 22(1):36-42. PubMed ID: 103558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial myxoma associated with systemic AA amyloidosis.
    Wens R; Goffin Y; Pepys MB; Kutnowski M; Van Beers D; Decoodt P; Verbanck M
    Arch Intern Med; 1989 Feb; 149(2):453-4. PubMed ID: 2916891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy.
    Eklund KK
    Immunol Rev; 2007 Jun; 217():38-52. PubMed ID: 17498050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
    Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay of serum protein SAA in rhesus monkeys with secondary amyloidosis.
    Doepel FM; Glorioso JC; Newcomer CE; Skinner M; Abrams GD
    Lab Invest; 1981 Jul; 45(1):7-13. PubMed ID: 7253566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-atherogenic potential of serum amyloid A peptides.
    Kisilevsky R; Tam SP; Ancsin JB
    Curr Opin Investig Drugs; 2008 Mar; 9(3):265-73. PubMed ID: 18311662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory findings and serum levels of amyloid A and soluble interleukin-2 receptors in patients with renal amyloidosis].
    Rysavá R; Merta M; Tesar V; Zabka J; Spicka I; Stejskalová A; Vernerová Z
    Cas Lek Cesk; 1998 Feb; 137(4):107-9. PubMed ID: 9531732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.